LEADER 03225nam  22004575  450 
001 9910300442303321
005 20200705175813.0
010   $a3-319-91110-4
024 7 $a10.1007/978-3-319-91110-6
035   $a(CKB)4100000005958455
035   $a(MiAaPQ)EBC5507927
035   $a(DE-He213)978-3-319-91110-6
035   $a(PPN)229918824
035   $a(EXLCZ)994100000005958455
100   $a20180828d2018      u|             0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aT1-Mapping in Myocardial Disease$b[electronic resource] $ePrinciples and Applications /$fedited by Phillip C. Yang
205   $a1st ed. 2018.
210  1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2018.
215   $a1 online resource (118 pages)
311   $a3-319-91109-0 
327   $aFundamentals of Cardiac T1 Mapping -- T1 Mapping in Cardiac Hypertrophy -- T1 mapping in cardiomyopathy from cancer treatment -- Comparison of T1 mapping by cardiac MRI to non-cardiac MRI methods to evaluate cardiac fibrosis -- T1 Mapping in Aortic Stenosis -- T1 Mapping in Peri-Infarct Injury in Ischemic Cardiomyopathy -- T1 mapping in stem cell therapy -- T1 Mapping in Uncommon Non-Ischemic Cardiomyopathies.
330   $aThis book details the advances in cardiac MRI that have enabled quantitative tissue characterization of the myocardium using myocardial and blood T1 measurements, which have enabled reliable detection of diffuse pathological processes in both the cardiomyocytes and the interstitial cells of the myocardium. Evaluation of the native myocardial and interstitial fibrosis, and measurement of the extracellular volume fraction has allowed an unprecedented opportunity to elucidate the pathology, diagnosis and prognosis of cardiovascular disease. T1-Mapping in Myocardial Disease: Principles and Applications reviews a wide spectrum of significant cardiovascular disease and provides relevant guidance for the clinical implementation of this innovative technique. The specific topics covered include principles of T1-mapping in cardiovascular disease and the role of T1-mapping in hypertensive heart disease and hypertrophic cardiomyopathy, cardiotoxicity from cancer treatment, cardiacfibrosis, left ventricular hypertrophy in aortic stenosis, peri-infarct injury in ischemic cardiomyopathy, and stem cell therapy. This comprehensive coverage of the utility of T1-mapping in cardiovascular diseases will greatly appeal to the entire cardiovascular medicine and imaging communities. .
606   $aCardiology
606   $aRadiology
606   $aCardiology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33037
606   $aDiagnostic Radiology$3https://scigraph.springernature.com/ontologies/product-market-codes/H29013
615  0$aCardiology.
615  0$aRadiology.
615 14$aCardiology.
615 24$aDiagnostic Radiology.
676   $a616.1207548
702   $aYang$b Phillip C$4edt$4http://id.loc.gov/vocabulary/relators/edt
906   $aBOOK
912   $a9910300442303321
996   $aT1-Mapping in Myocardial Disease$91754037
997   $aUNINA